(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

OPKO’s Frost: BioReference Was a Tremendous Acquisition (Audio)

OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0d06fa49-ba79-4845-b091-ae3c00a1c875/transcript

Advertisement